Suppr超能文献

缓激肽生成在创伤弧菌血管内播散中的作用及缓激肽拮抗剂对其侵袭的预防作用

Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist.

作者信息

Maruo K, Akaike T, Ono T, Maeda H

机构信息

Department of Dermatology, Kumamoto University School of Medicine, Japan.

出版信息

Infect Immun. 1998 Feb;66(2):866-9. doi: 10.1128/IAI.66.2.866-869.1998.

Abstract

Involvement of bradykinin generation in bacterial invasion was examined by using a gram-negative bacillus, Vibrio vulnificus, which is known to invade the blood circulatory system and cause septicemia. V. vulnificus was injected intraperitoneally (i.p.) into mice with or without bradykinin or a bradykinin (B2 receptor) antagonist. Dissemination of V. vulnificus from peritoneal septic foci to the circulating blood was assessed by counting of viable bacteria in venous blood by use of the colony-forming assay. Intravascular dissemination of V. vulnificus in mice was significantly potentiated by simultaneous injection with bradykinin but was markedly reduced by coadministration with the B2 antagonist D-Arg,[Hyp3, Thi(5,8), D-Phe7]-bradykinin. Furthermore, V. vulnificus lethality was significantly increased when bradykinin was administered simultaneously with the bacillus, whereas it was definitely suppressed by treatment with D-Arg,[Hyp3, Thi(5,8), D-Phe7]-bradykinin. Similarly, ovomacroglobulin, a potent inhibitor of the V. vulnificus protease, showed a strong suppressive effect on the V. vulnificus septicemia. We also confirmed appreciable bradykinin production in the primary septic foci in the mouse peritoneal cavity after i.p. inoculation with V. vulnificus. It is thus concluded that bradykinin generation in infectious foci is critically involved in facilitation of intravascular dissemination of V. vulnificus.

摘要

利用革兰氏阴性杆菌创伤弧菌(已知其可侵入血液循环系统并导致败血症),研究缓激肽生成在细菌侵袭中的作用。将创伤弧菌腹腔注射到注射或未注射缓激肽或缓激肽(B2受体)拮抗剂的小鼠体内。通过使用菌落形成试验对静脉血中的活菌进行计数,评估创伤弧菌从腹膜感染灶向循环血液中的扩散情况。与缓激肽同时注射可显著增强创伤弧菌在小鼠体内的血管内扩散,但与B2拮抗剂D-Arg,[Hyp3,Thi(5,8),D-Phe7]-缓激肽共同给药则可显著降低扩散。此外,当缓激肽与该细菌同时给药时,创伤弧菌的致死率显著增加,而用D-Arg,[Hyp3,Thi(5,8),D-Phe7]-缓激肽治疗则可明显抑制致死率。同样,卵巨球蛋白是创伤弧菌蛋白酶的有效抑制剂,对创伤弧菌败血症有很强的抑制作用。我们还证实,腹腔接种创伤弧菌后,小鼠腹腔原发性感染灶中有明显的缓激肽产生。因此得出结论,感染灶中缓激肽的生成在促进创伤弧菌的血管内扩散中起关键作用。

相似文献

3
Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin.
Agents Actions Suppl. 1993;42:159-65. doi: 10.1007/978-3-0348-7397-0_13.
4
Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection.
Microbiol Immunol. 2000;44(11):871-8. doi: 10.1111/j.1348-0421.2000.tb02577.x.
6
Clinical infections of Vibrio vulnificus: a case report and review of the literature.
J Emerg Med. 1998 Jan-Feb;16(1):61-6. doi: 10.1016/s0736-4679(97)00230-8.
8
[Vibrio vulnificus infection: clinical and bacteriological analysis of four cases].
Kansenshogaku Zasshi. 1999 Feb;73(2):149-55. doi: 10.11150/kansenshogakuzasshi1970.73.149.
9
Role of the protease in the permeability enhancement by Vibrio vulnificus.
Microbiol Immunol. 1988;32(10):1025-32. doi: 10.1111/j.1348-0421.1988.tb01467.x.
10
Prognostic factors and antibiotics in Vibrio vulnificus septicemia.
Arch Intern Med. 2006 Oct 23;166(19):2117-23. doi: 10.1001/archinte.166.19.2117.

引用本文的文献

1
-A Review with a Special Focus on Sepsis.
Microorganisms. 2025 Jan 10;13(1):128. doi: 10.3390/microorganisms13010128.
2
The role of Vibrio vulnificus virulence factors and regulators in its infection-induced sepsis.
Folia Microbiol (Praha). 2020 Apr;65(2):265-274. doi: 10.1007/s12223-019-00763-7. Epub 2019 Dec 16.
3
Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells.
Clin Exp Immunol. 2010 Dec;162(3):528-36. doi: 10.1111/j.1365-2249.2010.04270.x. Epub 2010 Oct 21.
4
Vibrio vulnificus: disease and pathogenesis.
Infect Immun. 2009 May;77(5):1723-33. doi: 10.1128/IAI.01046-08. Epub 2009 Mar 2.
6
Specificity of a Vibrio vulnificus aminopeptidase toward kinins and other peptidyl substrates.
J Bacteriol. 2006 Mar;188(6):2056-62. doi: 10.1128/JB.188.6.2056-2062.2006.
7
Staphylococcus aureus induces release of bradykinin in human plasma.
Infect Immun. 2001 Jun;69(6):3877-82. doi: 10.1128/IAI.69.6.3877-3882.2001.
8
Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases.
Jpn J Cancer Res. 2001 Apr;92(4):439-51. doi: 10.1111/j.1349-7006.2001.tb01114.x.
9
Construction and phenotypic evaluation of a Vibrio vulnificus vvpE mutant for elastolytic protease.
Infect Immun. 2000 Sep;68(9):5096-106. doi: 10.1128/IAI.68.9.5096-5106.2000.
10
Metalloprotease is not essential for Vibrio vulnificus virulence in mice.
Infect Immun. 2000 Jun;68(6):3569-73. doi: 10.1128/IAI.68.6.3569-3573.2000.

本文引用的文献

1
Activation of human matrix metalloproteinases by various bacterial proteinases.
J Biol Chem. 1997 Feb 28;272(9):6059-66. doi: 10.1074/jbc.272.9.6059.
2
Role of microbial proteases in pathogenesis.
Microbiol Immunol. 1996;40(10):685-99. doi: 10.1111/j.1348-0421.1996.tb01129.x.
4
Are bacterial proteinases pathogenic factors?
Trends Microbiol. 1995 Oct;3(10):405-7. doi: 10.1016/s0966-842x(00)88988-x.
7
Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs.
FEMS Microbiol Lett. 1993 Nov 15;114(1):109-14. doi: 10.1111/j.1574-6968.1993.tb06559.x.
8
Pathogenesis of pneumococcal infection.
N Engl J Med. 1995 May 11;332(19):1280-4. doi: 10.1056/NEJM199505113321907.
9
Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus.
Infect Immun. 1984 Aug;45(2):458-63. doi: 10.1128/iai.45.2.458-463.1984.
10
Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease.
J Biochem. 1984 Sep;96(3):739-49. doi: 10.1093/oxfordjournals.jbchem.a134892.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验